Revasum, Inc. reported earnings results for the half year ended July 02, 2023. For the half year, the company reported sales was USD 9.54 million compared to USD 7.41 million a year ago. Net loss was USD 3.64 million compared to USD 5.32 million a year ago.

Basic loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago.